This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ensoltek Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Je Wook Lee: Innovator in Peptide Research
Introduction
Je Wook Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of peptide research, particularly in the treatment and prevention of cartilage damage and arthritis. His innovative work has led to the development of a unique peptide that holds promise for medical applications.
Latest Patents
Je Wook Lee holds a patent for a peptide represented by the formula (I) of X-Leu-X-Leu-X, where X represents specific amino acids such as Glu, Asp, His, Lys, and Arg. This invention provides a composition for the treatment or prevention of cartilage damage and arthritis. The peptide is effective in regenerating cartilage tissue and inhibiting the expression of enzymes that degrade cartilage. It also shows potential in preventing cartilage ossification.
Career Highlights
Throughout his career, Je Wook Lee has worked with notable companies, including Ensoltek Co., Ltd. and Ensol Biosciences Inc. His experience in these organizations has contributed to his expertise in peptide research and development.
Collaborations
Je Wook Lee has collaborated with esteemed colleagues such as Hae Jin Kim and Young Joon Kwon. These partnerships have further enhanced his research capabilities and innovation in the field.
Conclusion
Je Wook Lee's contributions to peptide research are noteworthy, particularly in the context of treating cartilage damage and arthritis. His innovative patent reflects his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile